Annual Drug Patent Expirations for AYVAKIT
Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. There are three patents protecting this drug.
This drug has thirty-one patent family members in twenty-eight countries.
The generic ingredient in AYVAKIT is avapritinib. Additional details are available on the avapritinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com